Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic

Veran Medical Technologies Announces Intellectual Property Agreement With
Medtronic

Expands Veran's electromagnetic (EM) navigation for oncology procedures.

ST LOUIS, June 1 /PRNewswire/ -- Veran Medical Technologies announced today
that it has entered into an agreement with Medtronic surrounding intellectual
property. Veran secured a worldwide license to intellectual property from
Medtronic related to electromagnetic navigation. The Navigation division of
Medtronic has developed significant intellectual property in the field of
electromagnetic navigation through its StealthStation(R) AxiEM(TM) Navigation
System for use in neuro, spine, and ENT surgery. The licensing of the
Medtronic electromagnetic navigation and registration patents will enable
Veran to expand its IG4 line of product capabilities and market breadth in the
minimally invasive interventional oncology field. Veran is currently
marketing the IG4 - X-Thoracic Navigation System and intends to launch an IG4
- Endobronchial Navigation System, pending FDA Approval.

"This license agreement with Medtronic represents an extremely important
expansion to our existing intellectual property portfolio and product
pipeline," said Jerome R. Edwards, Veran president and chief executive
officer. "Veran is now uniquely positioned with a substantial intellectual
property portfolio, products that integrate seamlessly into clinical workflow,
an experienced team of medical technology innovators, and an absolute
commitment to improving the standard of care in minimally invasive
interventional oncology procedures."

About Veran Medical Technologies, Inc.
Veran Medical Technologies is a privately held image guided medical device
company focused on developing the next standard of care for minimally invasive
delivery of interventional oncology therapies. Veran provides proprietary 4D
registration capability for precise targeting of lesions via its FDA cleared
platform. The Veran platform aims to reduce procedure time, reduce radiation
exposure for the clinical staff, and increase targeting accuracy enabling
physicians to cost effectively treat patients with reduced co-morbidity risk.
Veran Medical Technologies is headquartered in St. Louis, MO.

http://www.veranmedical.com

SOURCE Veran Medical Technologies

Jerome R. Edwards, President and CEO of Veran Medical Technologies, Inc.,
+1-314-659-8500